HIV/AIDS
Reports on HIV/AIDS findings from McGill University provide new insights
Published in Biotech Business Week, January 5th, 2009
Research findings, 'Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase,' are discussed in a new report. According to recent research from Montreal, Canada, "Entecavir (ETV) is a potent antiviral nucleoside analogue that is used to treat hepatitis B virus (HBV) infection. Recent clinical studies have demonstrated that ETV is also active against the human immunodeficiency virus type 1 (HIV-1)."
"Unlike all approved nucleoside analogue reverse transcriptase RT) inhibitors (NRTIs), ETV contains a 3'-hydroxyl group that allows further nucleotide incorporation events to occur. Thus, the mechanism of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Instituto Gulbenkian de Ciencia
First experimental evidence for speedy adaptation to pesticides by worm species - JAMA and Archives Journals
Among older adults, prescription and over-the-counter medications are commonly used together - MedInsight Research Institute
New study shows that a cough medicine ingredient could effectively treat prostate cancer - NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Hepatitis C treatment reduces the virus but liver damage continues - Research
Blind man walking: With no visual awareness, man navigates obstacle course flawlessly - Saint Louis University
Using math to understand hep. C: Patterns paint picture of who will respond to treatment - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
